{"text": ["Incyte", "(INCY)", "Collaborates", "with", "Innovent", "for", "3", "Candidates"], "created_at": "2018-12-17 22:07:17"}
{"text": ["Incyte", "(INCY)", "Collaborates", "with", "Innovent", "for", "3", "Candidates"], "created_at": "2018-12-17 22:07:17"}
{"text": ["Merck", "to", "Acquire", "Europe's", "Antelliq", "Group", "for", "$2.4", "Billion"], "created_at": "2018-12-17 22:06:43"}
{"text": ["Merck", "to", "Acquire", "Europe's", "Antelliq", "Group", "for", "$2.4", "Billion"], "created_at": "2018-12-17 22:06:43"}
{"text": ["Merck", "to", "Acquire", "Europe's", "Antelliq", "Group", "for", "$2.4", "Billion"], "created_at": "2018-12-17 20:22:08"}
{"text": ["Incyte", "(INCY)", "Collaborates", "with", "Innovent", "for", "3", "Candidates"], "created_at": "2018-12-17 19:53:07"}
{"text": ["7", "Major", "Pharmaceutical", "Stocks", "to", "Quarantine", "Now"], "created_at": "2018-12-17 17:25:09"}
{"text": ["Lilly", "(LLY)", "to", "Acquire", "Pain", "Candidate", "From", "Private", "Biotech"], "created_at": "2018-12-17 17:09:53"}
{"text": ["Lilly", "(LLY)", "to", "Acquire", "Pain", "Candidate", "From", "Private", "Biotech"], "created_at": "2018-12-17 17:09:53"}
{"text": ["J&J", "Dips", "10%", "as", "Reuters", "Says", "Company", "Knew", "of", "Asbestos", "in", "Talc"], "created_at": "2018-12-17 16:10:45"}
{"text": ["J&J", "Dips", "10%", "as", "Reuters", "Says", "Company", "Knew", "of", "Asbestos", "in", "Talc"], "created_at": "2018-12-17 16:10:45"}
{"text": ["Better", "Buy:", "Eli", "Lilly", "and", "Company", "vs.", "Merck", "&", "Co."], "created_at": "2018-12-17 15:10:08"}
{"text": ["Better", "Buy:", "Eli", "Lilly", "and", "Company", "vs.", "Merck", "&", "Co."], "created_at": "2018-12-17 15:10:08"}
{"text": ["Lilly", "(LLY)", "to", "Acquire", "Pain", "Candidate", "From", "Private", "Biotech"], "created_at": "2018-12-17 14:48:02"}
{"text": ["J&J", "Dips", "10%", "as", "Reuters", "Says", "Company", "Knew", "of", "Asbestos", "in", "Talc"], "created_at": "2018-12-17 14:22:02"}
{"text": ["Better", "Buy:", "Eli", "Lilly", "and", "Company", "vs.", "Merck", "&", "Co."], "created_at": "2018-12-17 13:18:00"}
{"text": ["Dow", "Jones", "Futures:", "The", "Worst", "Part", "About", "This", "Stock", "Market", "Rally"], "created_at": "2018-12-17 13:12:10"}
{"text": ["Lilly", "says", "Taltz", "superior", "to", "Humira", "in", "late-stage", "psoriatic", "arthritis", "trial"], "created_at": "2018-12-17 11:48:06"}
{"text": ["Lilly", "Announces", "Positive", "Top-Line", "Results", "for", "Taltz\u00ae", "(ixekizumab)", "vs.", "Humira\u00ae", "(adalimumab)", "in", "a", "Head-to-Head", "(SPIRIT-H2H)", "Superiority", "Study", "in", "Patients", "with", "Active", "Psoriatic", "Arthritis"], "created_at": "2018-12-17 11:45:00"}
{"text": ["Eli", "Lilly:", "Taltz", "Meets", "Primary", "And", "Secondary", "Endpoints", "In", "Spirit-H2H", "Study"], "created_at": "2018-12-17 07:00:00"}
{"text": ["Eli", "Lilly:", "Taltz", "Meets", "Primary", "And", "Secondary", "Endpoints", "In", "Spirit-H2H", "Study"], "created_at": "2018-12-17 07:00:00"}
